Skip to main content

Opinion: Letting academic medical centers make CAR-T drugs would save billions

By Stat News  
   November 20, 2019

Draw blood from someone with cancer. Engineer their blood cells to seek and destroy cancer. Reinfuse the cells and watch the cancer melt away. Chimeric antigen receptor T cell therapy (CAR-T) sounds like science fiction. But it’s the next frontier in cancer therapy.

Full story


Get the latest on healthcare leadership in your inbox.